Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Cardiac Toxicity|Cardiovascular Complications
Interventions: BIOLOGICAL: trastuzumab|DRUG: doxorubicin hydrochloride|GENETIC: polymorphism analysis|OTHER: laboratory biomarker analysis|OTHER: questionnaire administration|PROCEDURE: assessment of therapy complications|PROCEDURE: magnetic resonance imaging
Sponsor: Vanderbilt University
Collaborators: National Cancer Institute (NCI)